Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Recurrence

NCT03283384 2025-09-19

NEOLBC

Phase 2 Active not recruiting

100 enrolled

Breast

Breast Neoplasms

NCT03070366 2025-09-02

OMET

Phase 2 Active not recruiting

78 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04905316 2025-06-17

CHORUS

Phase 2 Active not recruiting

41 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06727357 2024-12-10

Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

Phase 2 Active not recruiting

38 enrolled

Breast

Breast Neoplasms

NCT06667050 2024-10-31

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Phase 2 Active not recruiting

58 enrolled

Gastrointestinal

Gastric Adenocarcinoma

NCT05400070 2024-10-18

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Phase 2 Active not recruiting

45 enrolled

Thoracic

Lung Neoplasms

NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

Phase 2 Active not recruiting

14 enrolled 14 charts

Gastrointestinal

Anus Neoplasms

NCT04230759 2024-09-19

RADIANCE

Phase 2 Active not recruiting

180 enrolled

Gastrointestinal

Anus Neoplasms

NCT03443856 2024-01-05

VESTIGE

Phase 2 Active not recruiting

197 enrolled

Gastrointestinal

Gastric and Esophagogastric Junction Adenocarcinoma

NCT05569811 2023-09-21

VALENTINE

Phase 2 Active not recruiting

120 enrolled

Breast

Breast Neoplasms

Clinical Trials

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

ILDR-03

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

MPM-PDT

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

RETINO2011

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

NEOLBC

OMET

CHORUS

Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Proton Therapy in Reducing Toxicity in Anal Cancer

RADIANCE

VESTIGE

VALENTINE